Health Care Technology
Company Overview of Medytox Solutions, Inc.
Medytox Solutions, Inc. offers clinical laboratory blood and urine testing services to physicians, clinics, and rehabilitation facilities in the United States. The company operates in two segments, Clinical Laboratory Operations and Medical Support Solutions. It focuses on providing urine and blood drug toxicology and pain medication monitoring programs. The company’s turn-key urine drug testing program allows physicians to monitor and treat patients. It also offers medical support services primarily to its clinical laboratories, as well as to its third party customers. The company was formerly known as Casino Players, Inc. and changed its name to Medytox Solutions, Inc. in 2011. Medytox Sol...
400 South Australian Avenue
West Palm Beach, FL 33401
Founded in 2005
Key Executives for Medytox Solutions, Inc.
Founder and Director
Total Annual Compensation: $320.2K
Chief Financial Officer
Total Annual Compensation: $311.6K
Chief Executive Officer of the Medytox Laboratories
Total Annual Compensation: $373.5K
Vice President of Operations
Total Annual Compensation: $352.2K
Vice President of Sales & Marketing
Total Annual Compensation: $353.0K
Compensation as of Fiscal Year 2013.
Medytox Solutions, Inc. Key Developments
Medytox Solutions, Inc. and CollabRx, Inc. Announces Executive Changes
Apr 16 15
Medytox Solutions, Inc. and CollabRx, Inc. announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions. Following the merger, Seamus Lagan will be CEO of the combined company. Thomas Mika and Dr. Paul Billings will be appointed to the combined company’s seven-member board, which will include the five current directors of Medytox. Mr. Mika will serve as Executive Chairman, as well as CEO of CollabRx, Inc., which will operate as a wholly-owned subsidiary of the combined companies.
Medytox Solutions, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2014
Apr 15 15
Medytox Solutions, Inc. reported consolidated earnings results for the year ended December 31, 2014. For the year, the company reported net revenues of approximately $57.9 million, which represented an increase of approximately $16 million, or 38%, from the approximately $41.9 million in net revenues reported for the year ended December 31, 2013. Income from operations was approximately $15.7 million, compared to income from operations of approximately $14.5 million for the 2013 Year. Net income attributable to common shareholders was $2,810,032 or $0.09 per diluted share compared to $5,658,619 or $0.19 per diluted share a year ago.
Medytox Solutions Mulls Acquisitions
Apr 6 15
Medytox Solutions, Inc. (OTCBB:MMMS) is seeking acquisitions. Seamus Lagan, Chief Executive Officer of Medytox Solutions, said, “As Medytox continues to expand through organic growth, acquisitions, and new partnerships, we hope to create many more jobs in Florida and beyond.”
Similar Private Companies By Industry
Recent Private Companies Transactions